Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Distinct pattern of E2F1 expression in human lung tumours: E2F1 is upregulated in small cell lung carcinoma

Abstract

The transcription factor E2F1 is a key component of cell cycle that acts to transactivate genes required for S phase entry. Thus, it plays an important role in cellular proliferation, oncogenesis and differentiation. In order to investigate its potential implication in human lung carcinogenesis, we studied E2F1 protein expression by Western blotting and immunohistochemistry in a series of 58 human lung tumours of all histological types. We showed that E2F1 product was overexpressed in 92% (24/26) of small cell lung carcinoma (SCLC) and in 50% (5/10) of large cell neuroendocrine carcinoma (LCNEC) whereas it was undetectable in 90% (10/11) of adenocarcinoma and 82% (9/11) of squamous carcinoma when compared to corresponding normal lung. No amplification was found but an increase in E2F1 mRNA expression was detected in 75% (18/24) of SCLC overexpressing E2F1 product. In these tumours and in contrast with NSCLC, upregulation of E2F1 product was associated with its nuclear accumulation and with overexpression of several of its target-genes. Moreover, E2F1 overexpression in NE lung tumours was significantly associated with a high KI67 index (P<0.0001) as well as a Bcl-2:Bax ratio >1 (P<0.001). Overall, these results demonstrate a distinct pattern of E2F1 expression in human lung tumours and suggest that its deregulation could be involved in the carcinogenesis of SCLC.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  • Allen KE, de la Luna S, Kerkhoven RM, Bernards R, La Thangue NB . 1997 J. Cell Sci. 110: 2819–2831

  • Bates S, Phillips AC, Clark PA, Stott F, Peters G, Ludwig RL, Vousden KH . 1998 Nature 395: 124–125

  • Brambilla E, Gazzeri S, Moro D, Caron de Fromentel C, Gouyer V, Jacrot M, Brambilla C . 1993 Am. J. Pathol. 143: 199–210

  • Brambilla E, Negoescu A, Gazzeri S, Lantuejoul S, Moro D, Brambilla C, Coll JL . 1996 Am. J. Pathol. 149: 1941–1952

  • Brambilla E, Moro D, Gazzeri S, Brambilla C . 1997 J. Path. 188: 351–360

  • Campanero MR, Flemington EK . 1997 Proc. Natl. Acad. Sci. USA 94: 2221–2226

  • Chiba I, Takahashi T, Nau M . 1990 Oncogene 5: 1603–1610

  • Chomczynski PT, Sacchi N . 1987 Ann. Biochem. 162: 156–159

  • De La Luna S, Burden MJ, Lee CW, La Thangue NB . 1996 J. Cell Sci. 109: 2443–2452

  • DeGregori J, Kowalik T, Nevins JR . 1995 Mol. Cell. Biol. 15: 4215–4224

  • DeGregori J, Leone G, Miron A, Jakoi L, Nevins JR . 1997 Proc. Natl. Acad. Sci. USA 94: 7245–7250

  • DeMuth JP, Jackson CM, Weaver DA, Crawford EL, Durzinsky DS, Durham SJ, Zaher A, Phillips ER, Khuder SA, Willey JC . 1998 Am. J. Respir. Cell. Mol. Biol. 19: 18–24

  • Dyson N . 1998 Genes Dev. 12: 2245–2262

  • Field SJ, Tsai FY, Kuo F, Zubagia AM, Kaelin WG, Livingston DM, Orkin SH, Greenberg ME . 1996 Cell 85: 549–561

  • Flemington EK, Speck SH, Kaelin WG . 1993 Proc. Natl. Acad. Sci. USA 90: 6914–6918

  • Gazzeri S, Brambilla E, Caron de Fromentel C, Gouyer V, Moro D, Perron P, Berger F, Brambilla C . 1994 Int. J. Cancer 58: 24–32

  • Gazzeri S, Gouyer V, Vourc'h C, Brambilla C, Brambilla E . 1998a Oncogene 16: 497–505

  • Gazzeri S, Della Valle V, Chaussade L, Brambilla C, Larsen CJ, Brambilla E . 1998b Cancer Res. 58: 3926–3931

  • Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H . 1984 J. Immunol. 133: 1710–1715

  • Gouyer V, Gazzeri S, Bolon I, Drevet C, Brambilla C, Brambilla E . 1998 Am. J. Respir. Cell Mol. Biol. 17: 1–9

  • Hateboer G, Kerkhoven RM, Shvarts A, Bernards R, Beijersbergen RL . 1996 Genes Dev. 10: 2960–2970

  • Helin K . 1998 Curr. Opin. Genet. Dev. 8: 28–35

  • Hofmann F, Martelli F, Livingston DM, Wang ZY . 1996 Genes Dev. 10: 2949–2959

  • Johnson DG, Schwarz JK, Cress WD, Nevins JR . 1993 Nature 365: 349–352

  • Johnson DG, Ohtani K, Nevins JR . 1994 Genes Dev. 8: 1514–1525

  • Kelley MJ, Nakagawa K, Steinberg SM, Mulshine JL, Kamb A, Johnson BE . 1997 J. Nat. Cancer. Inst. 87: 756–761

  • Kowalik TF, DeGregori J, Leone G, Jakoi L, Nevins JR . 1998 Cell Growth Differ. 9: 113–118

  • Leone G, DeGregori J, Sears R, Jakoi L, Nevins JR . 1997 Nature 387: 422–426

  • Lindeman GJ, Gaubatz S, Livingston DM, Ginsberg D . 1997 Proc. Natl. Acad. Sci. USA. 94: 5095–5100

  • Marti A, Wirbelauer C, Scheffner M, Krek W . 1999 Nature Cell Biol. 1: 14–19

  • Martin K, Trouche D, Hagemeier C, Sorensen TS, La Thangue NB, Kouzarides T . 1995 Nature 375: 691–694

  • Mittnacht S . 1998 Curr. Opin. Genet. Dev. 8: 21–27

  • Neuman E, Flemington EK, Sellers WR, Kaelin WG . 1994 Mol. Cell. Biol. 14: 6607–6615

  • Nevins JR . 1992 Science 258: 424–429

  • O'Connor DJ, Lam EWF, Griffin S, Zhong S, Leighton LC, Burbidge SA, Lu X . 1995 EMBO J. 14: 6184–6192

  • Phillips AC, Ernst MK, Bates S, Rice NR, Vousden KH . 1999 Mol. Cell. 4: 771–781

  • Pierce AM, Gimenez-Conti IB, Schneider-Broussard R, Martinez LA, Conti CJ, Johnson DG . 1998 Proc. Natl. Acad. Sci. USA 95: 8858–8863

  • Pierce AM, Schneider-Broussard R, Gimenez-Conti IB, Russell JL, Conti CJ, Johnson DG . 1999 Mol. Cell. Biol. 19: 6408–6414

  • Qin XQ, Livingston DM, Kaelin WG, Adams P . 1994 Proc. Natl. Acad. Sci. USA 91: 10918–10922

  • Shan B, Lee WH . 1994 Mol. Cell. Biol. 14: 8166–8173

  • Shan B, Durfee T, Lee WH . 1996 Proc. Natl. Acad. Sci. USA 93: 679–684

  • Sherr CJ . 1996 Science 274: 1672–1677

  • Travis WD, Colby TV, Corrin B, Shimosato Y, Brambilla E . 1999 WHO International Histological Classification of Tumours: Histological Typing of Lung and Pleural Tumours. Third Edition. Ed Springer

  • Vandel L, Kouzarides T . 1999 EMBO J. 18: 4280–4291

  • Vigo E, Muller H, Prosperini E, Hateboer G, Cartwright P, Moroni MC, Helin K . 1999 Mol. Cell. Biol. 19: 6379–6395

  • Volm M, Koomagi R, Rittgen W . 1998 Int. J. Cancer 79: 294–299

  • Wade Harper J, Elledge SJ . 1999 Nature Cell Biol. 1: E5–E7

  • Weintraub SJ, Chow K, Luo RX, Zhang SH, He S, Dean DC . 1995 Nature 375: 812–815

  • Wu CL, Zukerberg LR, Ngwu C, Harlow E, Lees JA . 1995 Mol. Cell. Biol. 15: 2536–2546

  • Wu X, Levine AJ . 1994 Proc. Natl. Acad. Sci. USA 91: 3601–3606

  • Xu HJ, Cagle PT, Hu SX, Li J, Benedict WF . 1996 Clin. Cancer Res. 2: 1169–1176

  • Yamasaki L, Jacks T, Bronson R, Goillot E, Harlow E, Dyson NJ . 1996 Cell 85: 537–548

  • Yang HL, Dong YB, Elliott MJ, Liu TJ, McMasters KM . 2000 Clin. Cancer Res. 6: 1579–1589

  • Yatabe Y, Masuda A, Koshikawa T, Nakamura S, Kuroishi T, Osada H, Takahashi T, Mitsudowi T, Takahashi T . 1998 Cancer Res. 58: 1042–1047

  • Zhang HS, Postigo AA, Dean DC . 1999 Cell 97: 53–61

Download references

Acknowledgements

This work was supported by grants from the Association pour la Recherche sur le Cancer, from the Comité Départemental de la Ligue contre le Cancer de l'Isère and from the Groupement des Entreprises Francaises dans la Lutte contre le Cancer. B Eymin was supported by INSERM (Poste Accueil).

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Eymin, B., Gazzeri, S., Brambilla, C. et al. Distinct pattern of E2F1 expression in human lung tumours: E2F1 is upregulated in small cell lung carcinoma. Oncogene 20, 1678–1687 (2001). https://doi.org/10.1038/sj.onc.1204242

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1204242

Keywords

This article is cited by

Search

Quick links